Related Experiment Video
Updated: Jul 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance
Jennifer D Zwicker1, Ramesh Lamsal2, Myla E Moretti3,4
1School of Public Policy, University of Calgary, 906 8th Ave S.W., 5th Floor, Calgary, AB, T2P 1H9, Canada. zwicker1@ucalgary.ca.
Insights
This paper provides guidance for economic evaluations of neurodevelopmental disorder interventions. Tailored pharmacoeconomic methods are essential for equitable resource allocation for affected children and families.
Area of Science:
- Pharmacoeconomics
- Neurodevelopmental Disorders
- Health Economics
Background:
- Neurodevelopmental disorders (NDDs) are lifelong conditions impacting cognitive, social, behavioral, and physical functioning from early childhood.
- The consequences of NDDs extend beyond healthcare, affecting education, social services, and family life.
- Standard economic evaluation methods need adaptation for NDD interventions to capture multi-sectoral impacts.
Purpose of the Study:
- To provide practical guidance for pharmacoeconomic evaluations of interventions for children with NDDs.
- To address challenges in defining analytic perspectives, identifying costs, selecting outcomes, incorporating spillover effects, and modeling long-term trajectories.
- To recommend tailored methods for credible, policy-relevant evaluations.
Main Methods:
- Synthesizing methodological literature and applied experience in pharmacoeconomics for NDDs.
- Addressing five key issues: analytic perspective, cost identification/valuation, outcome selection, spillover effects, and long-term modeling.
- Recommending specific approaches: societal perspective, comprehensive costing, combined outcome measures, inclusion of family impacts, equity analyses, and robust long-term modeling.
Main Results:
- Adoption of a societal perspective is recommended to capture multi-sectoral costs and benefits.
- Comprehensive, context-appropriate costing and a combination of generic and condition-specific outcome measures are advised.
- Explicit inclusion of caregiver/family impacts, equity analyses, and long time horizons using advanced modeling techniques are highlighted.
Conclusions:
- Tailored pharmacoeconomic methods are crucial for credible and policy-relevant evaluations of NDD interventions.
- Transparent reporting and alignment with international standards will enhance comparability and decision-maker uptake.
- Improved evaluations promote equitable resource allocation for children and families affected by NDDs.
Abstract:
Neurodevelopmental disorders are lifelong conditions with onset in early childhood that impair cognitive, social, behavioural and physical functioning. Their consequences extend beyond healthcare, shaping education, social and community services, and family life. Economic evaluations can guide payers by quantifying the value for money of interventions, but standard methods require adaptation for this context. This paper offers practical guidance for pharmacoeconomic evaluations of interventions for children with neurodevelopmental disorders, synthesising methodological literature and applied experience to articulate core challenges, recommend solutions and highlight emerging opportunities. Evaluations must address five inter-related issues: defining and justifying an analytic perspective that captures multi-sectoral costs and benefits; identifying and valuing direct, indirect and intangible costs across health, education and social domains; selecting outcomes sensitive to changes in child functioning and health-related quality of life that can be economically valued; incorporating spillover effects for caregivers and families; and modelling long-term developmental trajectories amid data scarcity and uncertainty. We recommend adopting a societal perspective; applying comprehensive context-appropriate costing; combining generic and condition-specific outcome measures; explicitly including caregiver and family impacts; integrating equity analyses; and using long time horizons supported by robust modelling such as microsimulation or agent-based approaches. Promising directions include capability-based frameworks and digital biomarkers to enable real-world measurement of function and quality of life. Tailored pharmacoeconomic methods are essential for credible policy-relevant evaluations of neurodevelopmental disorder interventions. Transparent reporting and alignment with international standards will improve comparability, support uptake by decision makers, and promote equitable resource allocation for children and families affected by neurodevelopmental disorders.
Related Concept Videos
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Intellectual Disability
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
